Montecito Bank & Trust Has $1.12 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Montecito Bank & Trust increased its holdings in Colgate-Palmolive (NYSE:CL) by 9.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,320 shares of the company’s stock after purchasing an additional 1,018 shares during the quarter. Montecito Bank & Trust’s holdings in Colgate-Palmolive were worth $1,120,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Apeiron RIA LLC raised its position in shares of Colgate-Palmolive by 5.1% during the fourth quarter. Apeiron RIA LLC now owns 7,745 shares of the company’s stock worth $704,000 after acquiring an additional 379 shares during the last quarter. Whalen Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $291,000. Wesbanco Bank Inc. raised its holdings in Colgate-Palmolive by 1.7% during the 4th quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock worth $1,370,000 after purchasing an additional 250 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Colgate-Palmolive by 2.2% in the 4th quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock worth $35,227,000 after purchasing an additional 8,293 shares during the period. Finally, Atomi Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 6.5% in the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock valued at $590,000 after purchasing an additional 394 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.98 on Friday. The business’s fifty day simple moving average is $92.00 and its 200 day simple moving average is $97.58. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12 month low of $80.03 and a 12 month high of $109.30. The firm has a market capitalization of $71.88 billion, a P/E ratio of 25.21, a price-to-earnings-growth ratio of 3.62 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.34% of the stock is owned by company insiders.

Analyst Ratings Changes

CL has been the topic of several recent analyst reports. Barclays dropped their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus dropped their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Finally, UBS Group reduced their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $101.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.